<?xml version="1.0" encoding="UTF-8"?>
<p id="JVEv5-para-0107">Global HIV-1 eradication remains elusive with 1.8 million new infections in 2017, often associated with late diagnosis, gaps in linkage to care and incomplete viral suppression. The importance of a multipronged approach was emphasised with the need to improve ARV tolerability and convenience, thus maximising adherence as well as optimising pharmacokinetics and tissue distribution. These features are key to pre-exposure prophylaxis (PrEP) effectiveness, a strategy known to prevent HIV-1 transmission that impacts on both its incidence and prevalence 
 <xref rid="JVEv5-bib-0026" ref-type="bibr">[26]</xref>.
</p>
